×

Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation

  • US 8,546,408 B2
  • Filed: 12/22/2010
  • Issued: 10/01/2013
  • Est. Priority Date: 07/12/2007
  • Status: Active Grant
First Claim
Patent Images

1. A crystalline form of 4-chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)-pyridin-3-yl]-3-trifluoromethyl-benzenesulfonamide sodium salt.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×